Samsung Electronics and Medtronic are teaming up to develop mobile apps to provide insight and access on diabetes data, including glucose monitoring information, for Medtronic's MiniMed Connect.
The MiniMed Connect device, announced simultaneously with the partnership news, offers providers faster and easier access to patient insulin pump and glucose data in a mobile environment, as well as remote alerts, which Medtronic says will allow for more real-time care plan adjustment capability.
The U.S. Food and Drug Administration-approved Connect device lets diabetics view insulin pump and glucose monitor data on a smartphone, and provides remote monitoring and text messages for caregivers. Medtronic will also be working with Glooko, which has a cloud-based diabetes management platform.
"Medtronic aims to transform diabetes by providing world-class integrated care, enabled by leading technologies, big data, and informatics," Alejandro Galindo, Medtronic vice president and general manager of the Intensive Insulin Management business said in an announcement.
The partnership is part of Samsung's mHealth strategy, announced late in 2014, which is focused on seeking out partners, including Microsoft and SAP, to advance mHealth services and device innovation. In April, Samsung teamed up with Partners HealthCare in a multi-phase mobile tech initiative, with the first project focused on creating remote mHealth apps and spurring clinical research for chronic disease management. In late 2014 Samsung also debuted a consumer health software development kit to ignite app building for its Samsung Architecture for Multimodal Interactions.
The Medtronic-Glooko partnership will allow Medtronic to integrate other health and wellness data sources, such as food, medication, fitness and biometric data with its CareLink platform. This data, combined with insight via the Connect diabetes data, will help patients manage the chronic condition.
"Glooko leverages mobile and Web-based views to organize all the information into consolidated analytics and insights that enable patients and healthcare providers to understand the impact of carbs and insulin, combined with other variables like exercise and biometric data," states the announcement.
For more information:
- read the Samsung partnership announcement
- here's the Glooko agreement announcement
- check out the FDA MiniMed announcement